Interactive role of adenosine and dopamine in the opiate withdrawal syndrome

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 2, 2003, Pages 113-118

  Stella, Luigi ^a   De Novellis, Vito ^a   Vitelli, Maria Redenta ^a   Capuano, Annalisa ^a   Mazzeo, Filomena ^a   Berrino, Liberato ^a   Rossi, Francesco ^a   Filippelli, Amelia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adenosine receptors; Dopamine; Microdialysis; Nucleus accumbens; Rat; Withdrawal syndrome

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; CYCLOHEXYLADENOSINE; DOPAMINE; MORPHINE SULFATE; NALOXONE; OPIATE;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUXISM; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DOPAMINERGIC SYSTEM; DRUG EFFECT; JUMPING; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE WITHRAWAL SYNDROME; RAT; RECEPTOR BLOCKING; WITHDRAWAL SYNDROME; WRITING;

ADENOSINE; ANIMALS; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; MORPHINE; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE; SUBSTANCE WITHDRAWAL SYNDROME; TRIAZOLES;

EID: 0042878686     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0773-9     Document Type: Article

References (40)

1. Acquas E, Carboni E, Di Chiara G (1991) Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol 193:133-138
2. Aghajanian GK, Kogan JH, Moghaddam B (1994) Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636:126-132
3. 2A adenosine antagonists. J Med Chem 39:1164-1171
4. Baumeister AA, Richard AL, Richmond-Landeche L, Hurry MJ, Waguespack AM (1992) Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome. Neuropharmacology 9:835-841
5. Coupar IM, Tran BL (2001) Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life Sci 69:779-790
6. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ (1999) Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of iv drug self-administration. Psychopharmacology (Berl) 143:254-60
7. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137. Erratum in: Drug Alcohol Depend 39:155 (1995)
8. Di Chiara G, Imperato A (1988) Opiates, alcohol and barbiturates preferentially stimulate dopamine-release in the limbic system: studies with brain dialysis in freely-moving rats. Ann NY Acad Sci 24:125-131
9. Dionyssopoulos T, Hope W, Coupar IM (1992) Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol Biochem Behav 42:201-206
10. 2-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther 294:531-538
11. El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, Vaugeois JM (2001) Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol 134:68-77
12. Feng YZ, Zhang RW, Rockhold RW, Ho IK (1995) Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem Res 20:675-680
13. Ferrè S, Fuxe K, von Euler G, Johansson B, Fredhoml BB (1992) Adenosine, dopamine interactions in the brain. Neuroscience 51:501-512
14. Gomaa AA, Moustafa SA, Farghali AA (1989) Adenosine triphosphate blocks opiate withdrawal symptoms in rats and in mice. Pharmacol Toxicol 64:111-115
15. Hutson PH, Sarna GS, Kantamanemi BD, Curzon G (1985) Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal and brain dialysis. J Neurochem 44:1266-1273
16. 2-adenosine antagonist in vitro and in vivo. FEBS Lett 323:141-144
17. Jaffe JH (1990) Drug addiction and drug abuse In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 552-573
18. Koob GF (2000) Neurobiology of addiction toward the development of new therapies. Ann N Y Acad Sci 909:170-85
19. Krystal JH Rasmussen K, Aghajanian GK (1990) Excitatory amino acid antagonists for opiate withdrawal (abstract). Am Psych Assoc Abstr 143:262
20. Michalska E, Malec D (1993) Agonist and antagonist of adenosine receptors and morphine withdrawal syndrome in rats. Pol J Pharmacol 45:1-9
21. 2A receptors. Trends Pharmacol Sci 17:364-372
22. Paxinos G, Watson C (1986) The rat brain in the stereotaxic coordinates, 2nd Edn. Academic Press, San Diego
23. Pothos E, Rada P, Mark GP, Hoebel BG (1991) Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566:348-350
24. Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein P (1991) NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur J Pharmacol 197:9-16
25. Rossetti ZL, Melis L, Carboni S, Gessa GL (1990) Dopamine release in tolerance and withdrawal from morphine or ethanol (abstract). Neurosci Lett 39:S184
26. Salem A, Hope W (1999) Role of endogenous adenosine in the expression of opiate withdrawal in rats. Eur J Pharmacol 369:39-42
27. Stanishevskaia AV, Khristoliubova NA,Vekshina NL, Varfolomeev SO, Anokhina IP (1991) The action of low doses of bromocryptin in experimental morphine abstinence in rats. Farmakol Toksikol 54:15-17
28. Stella L, de Novellis V, Maione S, Leyva J, D'Amico M, Berrino L, Filippelli A, Rossi F (1995) Relationship between purinergic and glutamatergic systems in the opiate withdrawal syndrome. Res Commun Mol Path Pharmacol 87:55-56
29. Stella L, de Novellis V, Maione S, Marabese I, Rossi F (1997) Role of A1 and A2A adenosine receptors in the opiate withdrawal syndrome. Res Commun Alcohol Subst Abuse18:141-148
30. Tanganelli S Antonelli T Morari M, Bianchi C Beani L (1991) Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 122:270-272
31. Tidey JW, Miczek KA (1992) Morphine withdrawal aggression: modification with D1 and D2 receptor agonists. Psychopharmacol 108:177-184
32. Tokuyama S, Wakabayashi H, Ho IK (1996) Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur J Pharmacol 295:123-129
33. Tokuyama S, Takahashi M, Yamamoto T (2000) On the role of glutamate within the locus coeruleus during the development of opioid dependence and on the expression of withdrawal from dependence on opioids. Nihon Shinkei Seishin Yakurigaku Zasshi 20:141-7
34. Trujillo K, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-89
35. Tse SYH, Wei ET (1986) Inhibition of the shake response in rats by adenosine and 2-chloroadenosine. Psychopharmacology 90:322-326
36. Wise RA, Bozarth MA (1982) Action of drugs abuse on brain reward system: an update with specific attentions to opiates. Pharmacol Biochem Behav 17:239-243
37. Zhang T, Feng YZ, Rockhold RW, Ho IK (1994) Naloxone-precipitated morphine withdrawal increases pontaine glutamate levels in the rat. Life Sci 55:25-31
38. Zhu H, Barr GA (2001) Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent. Synapse 40:282-293
39. 2A adenosine receptor antagonist. J Pharmacol Exp Ther 276:398-404
40. Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S (1996b) Binding of the radioligand (3H)-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist to rat striatal membranes. Br J Pharmacol 117:1381-1386